Education
About Us
Working with TipRanks
Follow Us
Adicet Bio (ACET)
NASDAQ:ACET
Total Valuation
Adicet Bio has a market cap or net worth of $36.97M. The enterprise value is -$53.05M.
Market Cap$36.97M
Enterprise Value-$53.05M
Share Statistics
Adicet Bio has 82.69M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding82.69M
Owened by Insiders15.64%
Owened by Instutions47.34%
Financial Efficiency
Adicet Bio’s return on equity (ROE) is -0.63 and return on invested capital (ROIC) is -62.57%.
Return on Equity (ROE)-62.76%
Return on Assets (ROA)-53.18%
Return on Invested Capital (ROIC)-62.57%
Return on Capital Employed (ROCE)-63.54%
Revenue Per Employee$0
Profits Per Employee-$770,539.474
Employee Count152
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Adicet Bio is -0.72. Adicet Bio’s PEG ratio is 0.01.
PE Ratio-0.72
PS Ratio0.00
PB Ratio0.45
Price to Fair Value0.45
Price to FCF-0.90
Price to Operating Cash Flow-0.92
PEG Ratio0.01
Income Statement
In the last 12 months, Adicet Bio had revenue of $0.00 and earned -$117.12M in profits. Earnings per share was -$1.34.
Revenue$0.00
Gross Profit-$3.25M
Operating Income-$127.62M
Pretax Income-$117.12M
Net Income-$117.12M
EBITDA-110.65M
Earnings Per Share (EPS)-1.34
Cash Flow
In the last 12 months, operating cash flow was -$92.38M and capital expenditures -$1.12M, giving a free cash flow of -$93.50M billion.
Operating Cash Flow-$92.38M
Free Cash Flow-$93.50M
Free Cash Flow per Share-$1.13
Dividends & Yields
Adicet Bio pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-110.61%
Earnings Yield-138.56%
Stock Price Statistics
Beta1.24
52-Week Price Change-75.45%
50-Day Moving Average0.83
200-Day Moving Average1.14
Relative Strength Index (RSI)38.86
Average Volume (3m)408.64K
Important Dates
Adicet Bio upcoming earnings date is May 20, 2025, After Close.
Last Earnings DateMar 6, 2025
Next Earnings DateMay 20, 2025
Ex-Dividend Date―
Financial Position
Adicet Bio as a current ratio of 9.29, with Debt / Equity ratio of 0.09
Current Ratio9.29
Quick Ratio9.29
Debt to Market Cap0.20
Net Debt to EBITDA0.31
Interest Coverage Ratio31.90K
Taxes
In the past 12 months, Adicet Bio has paid $5.72K in taxes.
Income Tax$5.72K
Effective Tax Rate0.00%
Enterprise Valuation
Adicet Bio EV to EBITDA ratio is -0.35, with an EV/FCF ratio of -0.48.
EV to Sales0.00
EV to EBITDA-0.35
EV to Free Cash Flow-0.48
EV to Operating Cash Flow-0.49
Balance Sheet
Adicet Bio has $176.30M in cash and marketable securities with $17.23M in debt, giving a net cash position of -$159.07M billion.
Cash & Marketable Securities$176.30M
Total Debt$17.23M
Net Cash-$159.07M
Net Cash Per Share-$1.92
Tangible Book Value Per Share$2.12
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Adicet Bio is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.00
Price Target Upside1011.11%
Analyst ConsensusModerate Buy
Analyst Count5
Revenue Growth Forecast
EPS Growth Forecast59.75%